Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835
Books209
All textbooksMedical textbooksHuman anatomyOrganisms & biodiversityOther sciences
Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›MR-Pro-adrenomedullin (MR-proADM) and Host Immune Response Biomarkers Evaluation of procalcitonin-guided antibiotic duration in Children with Infection for Stratification of Effectiveness: the PRECISE Study›Equality, diversity and inclusion

Continue where you left off ()

GO BEYOND THE PAGEReading is just the beginning.

Turn scientific reading into research. Compare studies, examine evidence, and organize your findings in EvidenceHelix Workspace.

Explore Research Workspace →

MR-Pro-adrenomedullin (MR-proADM) and Host Immune Response Biomarkers Evaluation of procalcitonin-guided antibiotic duration in Children with Infection for Stratification of Effectiveness: the PRECISE Study · Equality, diversity and inclusion

Equality, diversity and inclusion

CC BY 4.0 · National Institute for Health and Care Research · approximately 2 min read

Participant representation

To ensure our findings are generalisable and applicable to various demographic groups, the study research methodology was designed in a pragmatic way to minimise bias and promote inclusivity in participant recruitment.

The four recruiting sites for PRECISE were purposively spread across England, including sites in the South, Southeast, Southwest and Northwest. This allowed for broad geographical representation across socioeconomic backgrounds, ages, ethnicities to ensure diversity within our recruited population.

The baseline demographics of PRECISE participants are broadly reflective of the paediatric secondary care population in the UK. The PRECISE analysis data set included 305 children aged 72 hours up to 18 years, the median age of participants was 3.7 (IQR 1.3–9.2) years, with 176/305 (57.7%) of the sample being male. Only 18/305 (5.9%) of PRECISE participants had non-White ethnicity, which is lower than overall UK population statistics.

BATCH trial entry criteria were designed to be as inclusive as possible. Through the promotion the use of NHS language line translation services, and use of site screening logs to monitor eligible participants who were not recruited due to language barriers (n = 265, 9.1%). Consideration was given to translating patient facing documentation into different languages to aid recruitment, however, as there was a wide variation in the languages spoken, with no language(s) being most commonly used, translation was not undertaken.

The non-conditional payment of the voucher to participants should have reduced non-response bias and encouraged responding, and thus increased the representation of children treated in hospital for SBI, than could otherwise be achieved.

Reflections on your research team and wider involvement

The BATCH and PRECISE research team had substantial PPI in study planning, the funding application, study delivery and dissemination. The BATCH PPI lead and co-applicant is the Senior Patient and Public Involvement Policy Manager at NIHR Alder Hey Clinical Research Facility and University of Liverpool, who was able to ensure involvement and representation from parent and young people stakeholder groups. Trial meetings were held as hybrid or online, improving access for those with mobility problems, physical disabilities or those with busy schedules and limited time availability.

← Public and patient involvementReferences →

Attribution. Cherry-Ann Waldron; Philip Pallmann; Simon Schoenbuchner; Debbie Harris; Jolanta Bernatoniene; Katrina Cathie et al. (2026). MR-Pro-adrenomedullin (MR-proADM) and Host Immune Response Biomarkers Evaluation of procalcitonin-guided antibiotic duration in Children with Infection for Stratification of Effectiveness: the PRECISE Study. National Institute for Health and Care Research. Copyright © 2026 Waldron et al. Licensed under CC BY 4.0. NCBI Bookshelf NBK621507. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

In this chapter Contents

  • Equality, diversity and inclusion

Source

OpenStax source file ↗

Source record ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support